openPR Logo
Press release

Global Pancreatic Cancer Market Size, Share - Industry Trend and Forecast 2012 - 2018

11-09-2017 08:21 AM CET | Health & Medicine

Press release from: MarketResearchReports.biz

Global Pancreatic Cancer Market Size, Share - Industry Trend

Latest industry research report on: Global Pancreatic Cancer Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts

The objective of this report is to define, describe, and forecast the market on the basis of type, application, medical condition, and region. It provides detailed information regarding the major factors influencing the growth of the market. This report also tracks and analyzes competitive developments of the key players in terms of market developments, product portfolios, and financials.

Complete Report Details @ https://www.marketresearchreports.biz/reports/139164/pancreatic-cancer-global-industry-market-research-reports

The global pancreatic cancer drug market is projected to reach USD 1.2 billion by 2015. Among all the regions, the United States has recorded the maximum number of pancreatic cancer cases, which are about 30,000 patients each year. The survival rate is less than 5 years which acts as a major hurdle for the growth of this market.

The aggressive nature of pancreatic cancer and inadequate responses to the treatment acts as major obstacles in the treatment of such diseases. Moreover, pancreatic cancer is diagnosed when it is in its advanced stage, leading to increase in mortality rate of the patients affected by such diseases. Only 15% to 12% of patients are diagnosed early enough thus making it possible to remove the tumor surgically. The stages in pancreatic cancers include stage I, stage II, stage III and stage IV of which only stage I and stage II tumors can be removed surgically.

Request For Sample Report @ https://www.marketresearchreports.biz/sample/sample/139164

Eli Lilly’s Gemzar (Gemcitabine) dominates the pancreatic cancer drug as it is presently the most advanced drug therapy recommended for stage III, IV or advanced stage treatments. Eli Lilly's Gemzar (Gemcitabine) and Genentech/ OSI Pharmaceuticals/ Roche's Tarceva (Erlotinib) have captured the whole of the pancreatic cancer drug market as these are the only two approved therapies available for the treatment of pancreatic cancer. Of the two, Gemzar leads the market with about 55% share in the pancreatic cancer drugs market.

The uncontrolled growth of cells in the pancreas leads to pancreatic cancer. This abnormal cells growth keeps on dividing and forms lumps or a mass of tissues called tumors. Tumors disturb the normal functioning of the pancreas. Pancreatic cancer is classified based on whether it affects exocrine or endocrine functions of the pancreas. The most common type of pancreatic cancer is adenocarcinomas, which account for 95% of exocrine pancreatic cancers. Other types of pancreatic cancers that are associated with endocrine functions include adenosquamous carcinomas, squamous cell carcinomas, and giant cell carcinomas.

Have Any Query? Ask Our Expert @ https://www.marketresearchreports.biz/sample/enquiryBuy/139164

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact Us

State Tower

90 State Street, Suite 700

Albany, NY 12207

United States

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

Email: sales@marketresearchreports.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Pancreatic Cancer Market Size, Share - Industry Trend and Forecast 2012 - 2018 here

News-ID: 808552 • Views:

More Releases from MarketResearchReports.biz

Hydro-flyers Market: Moving Towards a Brighter Future
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in
Outdoor Floodlights: Technology and Market Dynamics
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume
Snow Helmets Market Future Prospects and Regional Outlook
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is

All 5 Releases


More Releases for Pancreatic

Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Panc …
Pancreatic cancer is one of the aggressive cancers that originate in the tissues of the pancreas and rapidly spreads to the nearby organs. Pancreatic cancer is the 12th most commonly occurring cancer in the world. According to the American Cancer Society, ~55,440 patients in the US are expected to be diagnosed with pancreatic cancer in 2018. Moreover, the ACS also reports that pancreatic cancer is the third leading cause of
Pancreatic Cancer Treatment
Pancreatic Cancer Treatment Market describes its growth, size, share, Forecast and trends to 2025 Pancreatic Cancer Treatment Market Production and Demand Analysis 2019 to 2025 Pancreatic Cancer Treatment Market 2019 Manufacturing Analysis and Development Forecast 2025 Pancreatic Cancer Treatment Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Pancreatic Market to Insight By 2025: Top Key Vendors Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease. Download the sample report at: https://www.pharmaproff.com/request-sample/1024 Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI
Pancreatic Cancer Pipeline Review H1 2019
Pancreatic Cancer - Pipeline Review, H1 2017 Summary Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2017, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and
Pancreatic Cancer Drug Pipeline Analysis
“Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each
Exocrine Pancreatic Insufficiency Market 2013
Transparency Market Research has published a new market report titled, “Exocrine Pancreatic Insufficiency Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 – 2023.” According to the report, the exocrine pancreatic insufficiency market is anticipated to expand at a CAGR of 8.3% from 2015 to 2023 to reach US$2.85 Bn by 2023. Browse the full Exocrine Pancreatic Insufficiency Market – (Therapeutic – Pancreatic Enzyme Replacement Therapy (Creon, Zenpep,